TomoTherapy to Present at Merrill Lynch Conference
MADISON, Wis. – Jan. 28, 2008 – TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Dr. Fred Robertson, CEO, and Steve Hathaway, CFO, will present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 6, at 1:40 p.m., ET. The conference is scheduled for February 5-7 at the Grand Hyatt Hotel in New York City.
Mr. Hathaway and Dr. Robertson will address investors, portfolio managers and analysts.
A live Webcast of this presentation will be available on the Investor Relations page of TomoTherapy.com. An archive of the Webcast will also be available for 30 days following the presentation.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, manufactures and sells the TomoTherapy® Hi·Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company is traded on the NASDAQ Global Select Market under the symbol TOMO.
28 Jan 2008
